Gene · 2817
Papers2,608
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,608
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Syndecan 2 proteoglycan serves as a hepatitis B virus cell attachment receptor. | J Virol | 2025 | 40569080 | PubTator, text mining | PubMed |
| CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights. | Front Immunol | 2025 | 40463393 | PubTator, text mining | PubMed |
| Structural Features of Glypicans and their Impact on Wnt Signaling in Cancer. | Proteoglycan Res | 2025 | 40416340 | PubTator, text mining | PubMed |
| The glycocalyx: a key target for treatment of severe acute pancreatitis-associated multiple organ dysfunction syndrome. | Hum Cell | 2025 | 40411704 | PubTator, text mining | PubMed |
| Does plasma membrane transbilayer asymmetry coupled to lipid nanodomains drive fast kinetics of FGF2 membrane translocation into the extracellular space? | Faraday Discuss | 2025 | 40375669 | PubTator, text mining | PubMed |
| Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer. | Ann Med | 2025 | 40372974 | PubTator, text mining | PubMed |
| Extracellular vesicles: From large-scale production and engineering to clinical applications. | J Tissue Eng | 2025 | 40322740 | PubTator, text mining | PubMed |
| Exomeres and supermeres: Current advances and perspectives. | Bioact Mater | 2025 | 40276541 | PubTator, text mining | PubMed |
| A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery. | Clin Transl Oncol | 2025 | 40198505 | PubTator, text mining | PubMed |
| Expanding ligand-receptor interaction networks for axon guidance: Structural insights into signal crosstalk and specificity. | Curr Opin Neurobiol | 2025 | 40117944 | PubTator, text mining | PubMed |
| Trastuzumab Decreases the Expression of G1/S Regulators and Syndecan-4 Proteoglycan in Human Rhabdomyosarcoma. | Int J Mol Sci | 2025 | 40076757 | PubTator, text mining | PubMed |
| Heparan sulfate regulates amphiregulin programming of tissue reparative lung mesenchymal cells during influenza A virus infection in mice. | Nat Commun | 2025 | 40032825 | PubTator, text mining | PubMed |
| miR-143-3p/TET1 Axis Regulates GPC1 Through DNA Methylation and Impairs the Malignant Biological Behaviour of HCC via the Hippo Signalling Pathway. | J Cell Mol Med | 2025 | 39823268 | PubTator, text mining | PubMed |
| Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review. | ACS Mater Au | 2025 | 39802146 | PubTator, text mining | PubMed |
| Diagnostic value of glypican-1; a new marker differentiating pulmonary squamous cell carcinoma from adenocarcinoma: immunohistochemical study on Egyptian series. | Clin Exp Med | 2025 | 39797955 | PubTator, text mining | PubMed |
| Distinct molecular properties and functions of small EV subpopulations isolated from human umbilical cord MSCs using tangential flow filtration combined with size exclusion chromatography. | J Extracell Vesicles | 2025 | 39783889 | PubTator, text mining | PubMed |
| The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells. | Nanomedicine (Lond) | 2025 | 39620421 | PubTator, text mining | PubMed |
| A Mem-dELISA platform for dual color and ultrasensitive digital detection of colocalized proteins on extracellular vesicles. | Biosens Bioelectron | 2025 | 39413723 | PubTator, text mining | PubMed |
| Network Pharmacology, Molecular Docking Analysis and Experiment Validations on Molecular Targets and Mechanisms of the Dispel-Scar Ointment in Scar Treatment. | Comb Chem High Throughput Screen | 2025 | 39171596 | PubTator, text mining | PubMed |
| Prolonged Cardiopulmonary Bypass Time-Induced Endothelial Dysfunction via Glypican-1 Shedding, Inflammation, and Matrix Metalloproteinase 9 in Patients Undergoing Cardiac Surgery. | Biomedicines | 2024 | 39857617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2817/papers?page=5